| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 31.691 | 143.869 | 114.591 | 220.593 |
| Total Income - EUR | - | - | - | - | - | - | 31.691 | 143.869 | 114.591 | 220.764 |
| Total Expenses - EUR | - | - | - | - | - | - | 298 | 27.246 | 110.237 | 70.489 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 31.392 | 116.624 | 4.354 | 150.275 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 30.460 | 113.516 | 3.380 | 143.652 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuro Cle S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 21 | 104.936 | 113.363 | 173.173 |
| Current Assets | - | - | - | - | - | - | 31.731 | 138.962 | 152.274 | 175.039 |
| Inventories | - | - | - | - | - | - | 0 | 1.715 | 0 | 422 |
| Receivables | - | - | - | - | - | - | 101 | 62 | 30 | 31 |
| Cash | - | - | - | - | - | - | 31.630 | 137.185 | 152.244 | 174.586 |
| Shareholders Funds | - | - | - | - | - | - | 30.501 | 144.112 | 137.723 | 266.839 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.251 | 99.787 | 127.914 | 82.520 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Cle S.r.l.